Summary
GlobalData's Medical Devices sector report, “Hernia Repair Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Hernia Repair Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hernia Repair Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Hernia Repair Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hernia Repair Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hernia Repair Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
Acera Surgical, Inc.
Advanced Medical Solutions Group plc
ARISTE Medical
ArTack Medical Ltd
Atrium Medical Corp
C. R. Bard Inc
Cleveland Clinic Hospital
Cytograft Tissue Engineering Inc
DSM Biomedical BV
Kerecis ehf
LifeBond Ltd.
Medprin Regenerative Medical Technologies Co Ltd
MicroPort Scientific Corp
Montana State University
Nanovis Incorporated
Soft Tissue Regeneration Inc
TissueGen Inc
University of Colorado
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Hernia Repair Devices Overview 6
3 Products under Development 7
3.1 Hernia Repair Devices - Pipeline Products by Stage of Development 7
3.2 Hernia Repair Devices - Pipeline Products by Segment 8
3.3 Hernia Repair Devices - Pipeline Products by Territory 9
3.4 Hernia Repair Devices - Pipeline Products by Regulatory Path 10
3.5 Hernia Repair Devices - Pipeline Products by Estimated Approval Date 11
3.6 Hernia Repair Devices - Ongoing Clinical Trials 12
4 Hernia Repair Devices - Pipeline Products under Development by Companies 13
4.1 Hernia Repair Devices Companies - Pipeline Products by Stage of Development 13
4.2 Hernia Repair Devices - Pipeline Products by Stage of Development 14
5 Hernia Repair Devices Companies and Product Overview 15
5.1 Acera Surgical, Inc. Company Overview 15
5.1.1 Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Advanced Medical Solutions Group plc Company Overview 16
5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 ARISTE Medical Company Overview 19
5.3.1 ARISTE Medical Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 ArTack Medical Ltd Company Overview 20
5.4.1 ArTack Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 Atrium Medical Corp Company Overview 21
5.5.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 C. R. Bard Inc Company Overview 22
5.6.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 Cleveland Clinic Hospital Company Overview 23
5.7.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 Cytograft Tissue Engineering Inc Company Overview 24
5.8.1 Cytograft Tissue Engineering Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.9 DSM Biomedical BV Company Overview 25
5.9.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 25
5.10 Kerecis ehf Company Overview 26
5.10.1 Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 26
5.11 LifeBond Ltd. Company Overview 27
5.11.1 LifeBond Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27
5.12 Medprin Regenerative Medical Technologies Co Ltd Company Overview 28
5.12.1 Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
5.13 MicroPort Scientific Corp Company Overview 29
5.13.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.14 Montana State University Company Overview 30
5.14.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 30
5.15 Nanovis Incorporated Company Overview 31
5.15.1 Nanovis Incorporated Pipeline Products & Ongoing Clinical Trials Overview 31
5.16 Soft Tissue Regeneration Inc Company Overview 32
5.16.1 Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.17 TissueGen Inc Company Overview 33
5.17.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.18 University of Colorado Company Overview 34
5.18.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 34
6 Hernia Repair Devices- Recent Developments 35
6.1 Mar 15, 2017: Admedus Appoints Wayne Paterson As Chief Executive Officer 35
6.2 Mar 14, 2017: Advanced Medical Solutions Group: Unaudited preliminary Results for the year ended 31 December 2016 36
6.3 Mar 14, 2017: Surgical Innovations Group: Final results for the year ended 31 December 2016 37
6.4 Mar 14, 2017: Admedus Appoints John Seaberg As Chairman 43
6.5 Mar 06, 2017: Via Surgical Signs Exclusive U.S Distribution Agreement With Progressive Medical and Will Launch its FasTouch Fixation System at the Americas Hernia Society Conference, March 8-11 in Cancun, Mexico 44
6.6 Feb 24, 2017: Admedus Announces Half Yearly Report 45
6.7 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 47
6.8 Dec 23, 2016: Admedus Finishes Year With Growing Revenue After Completing Code Red Review 49
6.9 Nov 22, 2016: Soft Tissue Regeneration Raises USD1.5 Million in Venture Financing 50
6.10 Nov 03, 2016: DSM Q3 2016 Results 50
6.11 Nov 01, 2016: TELA Bio Announces OviTex Reinforced BioScaffolds Implanted in 100 Hernia Repair Procedures 52
6.12 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 53
6.13 Oct 21, 2016: Colorado Therapeutics Receives 510(k) Clearance for a Novel Xenograft Implant for Soft Tissue Repairs 54
6.14 Oct 06, 2016: Harbor MedTech Raises Additional USD1.46 Million in Venture Financing 55
6.15 Sep 25, 2016: Admedus Strengthens Management Team 55
6.16 Sep 14, 2016: Nanovis to Raises USD3.8 Million in Venture Financing 56
6.17 Sep 14, 2016: Advanced Medical Solutions Group: Interim Results for the six months ended 30 June 2016 56
6.18 Sep 13, 2016: Nanovis Raises USD1.1 Million in Venture Financing 68
6.19 Sep 09, 2016: Admedus Announces Settlement Of Federal Court Proceedings 68
6.20 Aug 31, 2016: Surgical Innovations Group: Interim results for the six months ended 30 June 2016 68
6.21 Aug 30, 2016: MPSC Announces 2016 Interim Results 70
6.22 Aug 26, 2016: Admedus Appoints New Chief Financial Officer 72
6.23 Aug 12, 2016: Kerecis Fish Skin Wound Treatment Available for the VA and Other Government Agencies 73
6.24 Jul 29, 2016: Admedus Raises USD4 Million in Rights Offering of Shares 73
6.25 Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016 74
6.26 Jul 20, 2016: Admedus Announces Financial Report 75
6.27 Jul 11, 2016: Dongguan Keweis Polypropylene Hernia Mesh Granted CFDA Approval 76
6.28 Jun 15, 2016: Results from Studies of OviTex Reinforced BioScaffolds Presented at Abdominal Wall Reconstruction Conference 77
6.29 May 23, 2016: Admedus: Resignation Of Managing Director 77
6.30 May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference 77
7 Appendix 79
7.1 Methodology 79
7.2 About GlobalData 82
7.3 Contact Us 82
7.4 Disclaimer 82
1.1 List of Tables
Table 1: Hernia Repair Devices - Pipeline Products by Stage of Development 7
Table 2: Hernia Repair Devices - Pipeline Products by Segment 8
Table 3: Hernia Repair Devices - Pipeline Products by Territory 9
Table 4: Hernia Repair Devices - Pipeline Products by Regulatory Path 10
Table 5: Hernia Repair Devices - Pipeline Products by Estimated Approval Date 11
Table 6: Hernia Repair Devices - Ongoing Clinical Trials 12
Table 7: Hernia Repair Devices Companies - Pipeline Products by Stage of Development 13
Table 8: Hernia Repair Devices - Pipeline Products by Stage of Development 14
Table 9: Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 10: Surgical Mesh - Hernia - Product Status 15
Table 11: Surgical Mesh - Hernia - Product Description 15
Table 12: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 13: LiquiBand Fix8 - Product Status 16
Table 14: LiquiBand Fix8 - Product Description 17
Table 15: Liquiband Fix8 Adhesive - Open Hernia Repair - Product Status 17
Table 16: Liquiband Fix8 Adhesive - Open Hernia Repair - Product Description 17
Table 17: Advanced Medical Solutions Group plc - Ongoing Clinical Trials Overview 18
Table 18: LiquiBand Fix8 - Randomized Single-center Study on Laparoscopic Groin Hernia Repair by a 3D ENDOLAP Visible with and Without LiquiBand Fix 8 Mesh Fixation 18
Table 19: ARISTE Medical Pipeline Products & Ongoing Clinical Trials Overview 19
Table 20: Drug-eluting Hernia Mesh - Product Status 19
Table 21: Drug-eluting Hernia Mesh - Product Description 19
Table 22: ArTack Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
Table 23: eTack Device - Product Status 20
Table 24: eTack Device - Product Description 20
Table 25: Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 21
Table 26: Next Generation Omega 3 Coated Surgical Mesh - Product Status 21
Table 27: Next Generation Omega 3 Coated Surgical Mesh - Product Description 21
Table 28: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 29: Phasix Expansion - Product Status 22
Table 30: Phasix Expansion - Product Description 22
Table 31: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 23
Table 32: Reinforced Extracellular Matrix Device - Product Status 23
Table 33: Reinforced Extracellular Matrix Device - Product Description 23
Table 34: Cytograft Tissue Engineering Inc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 35: Lifeguard Patch - Product Status 24
Table 36: Lifeguard Patch - Product Description 24
Table 37: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 25
Table 38: Hernia Glue - Product Status 25
Table 39: Hernia Glue - Product Description 25
Table 40: Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 26
Table 41: Kerecis Omega3 Hernia - Product Status 26
Table 42: Kerecis Omega3 Hernia - Product Description 26
Table 43: LifeBond Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 44: LifeMesh - Product Status 27
Table 45: LifeMesh - Product Description 27
Table 46: Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
Table 47: RETISSUE Hernia Repair Patch - Product Status 28
Table 48: RETISSUE Hernia Repair Patch - Product Description 28
Table 49: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 50: Hernia Patch - Product Status 29
Table 51: Hernia Patch - Product Description 29
Table 52: Montana State University Pipeline Products & Ongoing Clinical Trials Overview 30
Table 53: Lipid-Coated Surgical Mesh - Product Status 30
Table 54: Lipid-Coated Surgical Mesh - Product Description 30
Table 55: Nanovis Incorporated Pipeline Products & Ongoing Clinical Trials Overview 31
Table 56: Hernia Mesh - Product Status 31
Table 57: Hernia Mesh - Product Description 31
Table 58: Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 59: 3D Surgical Mesh - Hernia Repair - Product Status 32
Table 60: 3D Surgical Mesh - Hernia Repair - Product Description 32
Table 61: TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 62: ELUTE Fiber - Hernia Mesh - Product Status 33
Table 63: ELUTE Fiber - Hernia Mesh - Product Description 33
Table 64: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 34
Table 65: SMP Hernia Repair Patch - Product Status 34
Table 66: SMP Hernia Repair Patch - Product Description 34
Table 67: Glossary 81
1.2 List of Figures
Figure 1: Hernia Repair Devices - Pipeline Products by Stage of Development 7
Figure 2: Hernia Repair Devices - Pipeline Products by Segment 8
Figure 3: Hernia Repair Devices - Pipeline Products by Territory 9
Figure 4: Hernia Repair Devices - Pipeline Products by Regulatory Path 10
Figure 5: Hernia Repair Devices - Pipeline Products by Estimated Approval Date 11
Figure 6: Hernia Repair Devices - Ongoing Clinical Trials 12
